Tel Aviv-based QuantHealth, a provider of AI clinical trial simulation software, raised a $45M Series B led by Qumra Capital, taking its total funding to ~$70M (Cailey Gleeson/Fierce Healthcare)

Summary

Tel Aviv-based QuantHealth raised a $45 million Series B led by Qumra Capital, taking total funding to roughly $70 million. Its software uses AI to simulate clinical trials and help life-sciences teams make better R&D decisions.

Why it matters

Vertical AI still commands serious capital when it targets an expensive, regulated workflow and promises measurable efficiency. Clinical-trial simulation is attractive because the value proposition is tied to time saved and risk reduced, not just model novelty.

Founder/operator read

• The bar for AI in healthcare is rising: the pitch has to be operationally indispensable.
• Founders in regulated markets should frame the product around cost reduction, cycle-time improvement, or success-rate gains.

Original source

Read original